Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6097417, 14 pages
http://dx.doi.org/10.1155/2016/6097417
Review Article

Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review

1Facultad de Ciencias de la Cultura Física, Universidad Autónoma de Chihuahua, Circuito No. 1, Nuevo Campus Universitario, Apartado Postal 1552, 31240 Chihuahua, CHIH, Mexico
2Facultad de Medicina y Ciencias Biomédicas, Universidad Autónoma de Chihuahua, Circuito No. 1, Nuevo Campus Universitario, Apartado Postal 1552, 31240 Chihuahua, CHIH, Mexico

Received 27 November 2015; Revised 15 March 2016; Accepted 3 April 2016

Academic Editor: Kota V. Ramana

Copyright © 2016 Celia María Quiñonez-Flores et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England journal of medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Lajas, L. Abasolo, B. Bellajdel et al., “Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study,” Arthritis Care and Research, vol. 49, no. 1, pp. 64–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gibofsky, “Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis,” The American Journal of Managed Care, vol. 18, no. 13, supplement, pp. S295–S302, 2012. View at Google Scholar · View at Scopus
  4. L. I. Filippin, R. Vercelino, N. P. Marroni, and R. M. Xavier, “Redox signalling and the inflammatory response in rheumatoid arthritis,” Clinical and Experimental Immunology, vol. 152, no. 3, pp. 415–422, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Phaniendra, D. B. Jestadi, and L. Periyasamy, “Free radicals: properties, sources, targets, and their implication in various diseases,” Indian Journal of Clinical Biochemistry, vol. 30, no. 1, pp. 11–26, 2015. View at Publisher · View at Google Scholar
  6. B. Halliwell and J. M. C. Gutteridge, “Role of free radicals and catalytic metal ions in human disease: an overview,” Methods in Enzymology, vol. 186, pp. 1–85, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. I. Krinsky, “Mechanism of action of biological antioxidants,” Proceedings of the Society for Experimental Biology and Medicine, vol. 200, no. 2, pp. 248–254, 1992. View at Google Scholar
  9. C. A. Hitchon and H. S. El-Gabalawy, “Oxidation in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 6, no. 6, pp. 265–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Z. Hassan, T. A. Gheita, S. A. Kenawy, A. T. Fahim, I. M. El-Sorougy, and M. S. Abdou, “Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity,” International Journal of Rheumatic Diseases, vol. 14, no. 4, pp. 325–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Hadjigogos, “The role of free radicals in the pathogenesis of rheumatoid arthritis,” Panminerva Medica, vol. 45, no. 1, pp. 7–13, 2003. View at Google Scholar · View at Scopus
  12. B. Kalpakcioglu and K. Senel, “The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis,” Clinical Rheumatology, vol. 27, no. 2, pp. 141–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Q. Hassan, R. A. Hadi, Z. S. Al-Rawi, V. A. Padron, and S. J. Stohs, “The glutathione defense system in the pathogenesis of rheumatoid arthritis,” Journal of Applied Toxicology, vol. 21, no. 1, pp. 69–73, 2001. View at Publisher · View at Google Scholar
  14. C. H. Jeon, J.-K. Ahn, J.-Y. Chai et al., “Hypoxia appears at pre-arthritic stage and shows co-localization with early synovial inflammation in collagen induced arthritis,” Clinical and Experimental Rheumatology, vol. 26, no. 4, pp. 646–648, 2008. View at Google Scholar · View at Scopus
  15. C. Pacheco-Tena and S. A. Gonzalez-Chavez, “The danger model approach to the pathogenesis of the rheumatic diseases,” Journal of Immunology Research, vol. 2015, Article ID 506089, 23 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Datta, S. Kundu, P. Ghosh, S. De, A. Ghosh, and M. Chatterjee, “Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis,” Clinical Rheumatology, vol. 33, no. 11, pp. 1557–1564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Nakajima, Y. Aoki, Y. Shibata et al., “Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis,” Modern Rheumatology, vol. 24, no. 6, pp. 926–930, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. G. M. Thiele, M. J. Duryee, D. R. Anderson et al., “Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis,” Arthritis and Rheumatology, vol. 67, no. 3, pp. 645–655, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Nzeusseu Toukap, C. Delporte, C. Noyon et al., “Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis,” Free Radical Research, vol. 48, no. 4, pp. 461–465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. L. K. Stamp, I. Khalilova, J. M. Tarr et al., “Myeloperoxidase and oxidative stress in rheumatoid arthritis,” Rheumatology, vol. 51, no. 10, pp. 1796–1803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Staroń, G. Mąkosa, and M. Koter-Michalak, “Oxidative stress in erythrocytes from patients with rheumatoid arthritis,” Rheumatology International, vol. 32, no. 2, pp. 331–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. B. Desai, S. Manjunath, K. Sumangala, K. Chetana, and J. Vanishree, “Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study,” European Review for Medical and Pharmacological Sciences, vol. 14, no. 11, pp. 959–967, 2010. View at Google Scholar · View at Scopus
  23. Y. H. Rho, C. P. Chung, A. Oeser et al., “Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis,” Arthritis Care and Research, vol. 62, no. 10, pp. 1473–1480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Tetik, S. Ahmad, A. A. Alturfan et al., “Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients,” Indian Journal of Geo-Marine Sciences, vol. 47, no. 6, pp. 353–358, 2010. View at Google Scholar · View at Scopus
  25. L. Ediz, O. Hiz, H. Ozkol, E. Gulcu, M. Toprak, and M. F. Ceylan, “Relationship between anti-CCP antibodies and oxidant and anti-oxidant activity in patients with rheumatoid arthritis,” International Journal of Medical Sciences, vol. 8, no. 2, pp. 139–147, 2011. View at Google Scholar · View at Scopus
  26. G. A. Jacobson, S. J. Ives, C. Narkowicz, and G. Jones, “Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study,” Clinical Rheumatology, vol. 31, no. 11, pp. 1543–1547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. García-González, R. Gaxiola-Robles, and T. Zenteno-Savín, “Oxidative stress in patients with rheumatoid arthritis,” Revista de Investigación Clínica: Organo del Hospital de Enfermedades de la Nutrición, vol. 67, no. 1, pp. 46–53, 2015. View at Google Scholar
  28. M. Veselinovic, N. Barudzic, M. Vuletic et al., “Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity,” Molecular and Cellular Biochemistry, vol. 391, no. 1-2, pp. 225–232, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Kwaśny-Krochin, P. Głuszko, and A. Undas, “Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation,” Polskie Archiwum Medycyny Wewnetrznej, vol. 122, no. 6, pp. 270–276, 2012. View at Google Scholar · View at Scopus
  30. A. Karaman, D. N. Binici, and M. A. Melikoĝlu, “Comet assay and analysis of micronucleus formation in patients with rheumatoid arthritis,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 721, no. 1, pp. 1–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Alver, A. Şentürk, H. Çakirbay et al., “Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis,” Clinical Biochemistry, vol. 44, no. 17-18, pp. 1385–1389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Shah, A. Wanchu, and A. Bhatnagar, “Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis,” Immunobiology, vol. 216, no. 9, pp. 1010–1017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Kundu, P. Ghosh, S. Datta, A. Ghosh, S. Chattopadhyay, and M. Chatterjee, “Oxidative stress as a potential biomarker for determining disease activity in patients with Rheumatoid Arthritis,” Free Radical Research, vol. 46, no. 12, pp. 1482–1489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Aryaeian, M. Djalali, F. Shahram, S. H. Jazayeri, M. Chamari, and S. A. Nazari, “Beta-carotene, vitamin E, MDA, glutathione reductase and arylesterase activity levels in patients with active rheumatoid arthritis,” Iranian Journal of Public Health, vol. 40, no. 2, pp. 102–109, 2011. View at Google Scholar · View at Scopus
  35. W. Wang, Z. Jian, J. Guo, and X. Ning, “Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis,” Life Sciences, vol. 117, no. 1, pp. 19–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Hayashi, K. Satoi, N. Sato-Mito et al., “Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis,” Nutrition, vol. 28, no. 11-12, pp. 1109–1114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. B. T. Kurien and R. H. Scofield, “Autoimmunity and oxidatively modified autoantigens,” Autoimmunity Reviews, vol. 7, no. 7, pp. 567–573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Iuchi, F. Okada, K. Onuma et al., “Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production,” Biochemical Journal, vol. 402, no. 2, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. M. Thiele, D. J. Tuma, M. S. Willis et al., “Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant,” Alcoholism: Clinical and Experimental Research, vol. 22, no. 8, pp. 1731–1739, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. D. J. Tuma, M. L. Kearley, G. M. Thiele et al., “Elucidation of reaction scheme describing malondialdehyde—acetaldehyde—protein adduct formation,” Chemical Research in Toxicology, vol. 14, no. 7, pp. 822–832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Rantapää-Dahlqvist, B. A. W. de Jong, E. Berglin et al., “Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 48, no. 10, pp. 2741–2749, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Mishra, A. Singh, V. Chandra et al., “A comparative analysis of serological parameters and oxidative stress in osteoarthritis and Rheumatoid arthritis,” Rheumatology International, vol. 32, no. 8, pp. 2377–2382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. K. Hansson and P. Libby, “The immune response in atherosclerosis: a double-edged sword,” Nature Reviews Immunology, vol. 6, no. 7, pp. 508–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Surdacki, J. Martens-Lobenhoffer, A. Wloch et al., “Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration,” Metabolism, vol. 58, no. 3, pp. 316–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Miyazaki, H. Matsuoka, J. P. Cooke et al., “Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis,” Journal of Cardiology, vol. 33, no. 2, pp. 105–106, 1999. View at Google Scholar · View at Scopus
  46. S. Van Doornum, G. McColl, and I. P. Wicks, “Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?” Arthritis and Rheumatism, vol. 46, no. 4, pp. 862–873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, “Biomarkers of oxidative damage in human disease,” Clinical Chemistry, vol. 52, no. 4, pp. 601–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. J. Nicholls and S. L. Hazen, “Myeloperoxidase, modified lipoproteins, and atherogenesis,” Journal of Lipid Research, vol. 50, supplement, pp. S346–S351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Zheng, Z.-M. Zhong, S. Qin et al., “Advanced oxidation protein products induce inflammatory response in fibroblast-like synoviocytes through NADPH oxidase -dependent activation of NF-κB,” Cellular Physiology and Biochemistry, vol. 32, no. 4, pp. 972–985, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Jira, G. Spiteller, and A. Richter, “Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis,” Chemistry and Physics of Lipids, vol. 87, no. 1, pp. 81–89, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus